health care

Plus, fund managers outline the key trends shaping the sector.

Murdoch sits down with James McDonald, Co-PM for Pengana’s High Conviction Fund to discuss Titanium, Resources, Japan, Healthcare & more!

Forager's Steve Johnson and Seneca's Luke Laretive talk hot themes and hotter stocks

Murdoch speaks with Michael Frazis the MD & PM of Frazis Capital Partners about AI, Tech, Life Sciences & his new A.I. risk management tool.

Australian biotech and pharma had a number of key results in May with several stocks rallying. I look at 6 companies on the move.

Welcome to the first edition of the IIR Movers & Shakers report for Pharma & Biotech. Each month, we will be looking at those stocks that experience significant share...

While healthcare was clearly the lifeblood of the Aussie market over the last decade, the last two years have seen many of these long-term compounders barely register...

The Platypus team has always liked the health sector because it provides earnings certainty and offers defensive and quality characteristics that appeal to investors...

Growth is slowing, inflation pressures are building, but for companies with proven pricing power that also benefit from growth trends, inflation is nothing to fear. In...

Explosive growth in Asia’s middle-class is a structural trend offering compelling investment ideas. Shannon McConaghy, of VGI Partners, says over 1.5 billion people...